Jellagen launches JellaGel™, the first Collagen Type 0 Hydrogel taking on the market leading...
Jan 15 2021
Jellagen® Limited, a biotechnology company manufacturing high-value Collagen Type 0 derived from jellyfish, announce the launch of their JellaGel™ Hydrogel. 3-dimensaional Hydrogels allow cells to grow and interact with all of their...
New cancer models mimic aspects of mechanical environment within the body
As cancer and tumor cells move inside the human body, they impart and are subject to mechanical forces. In order to understand how these actions affect cancer cell growth, spread, and invasion, a team...
New method uses artificial intelligence to map intestinal bacteria using feces
The intestines and their bacteria are sometimes called our ’second brain’, but studying these bacteria in their natural environment is difficult. Now researchers from the University of Copenhagen have developed a method that uses...
Nanollose non-executive director demonstrates confidence in biotechnology strategy with on-market purchase – Proactive Investors...
Nanollose Ltd (ASX:NC6) non-executive director Winton Willesee has demonstrated confidence in the company’s biotechnology strategy utilising tree-free fibres with the purchase of shares in an on-market transaction. Willesee purchased 170,000 shares worth a total...
Acute itching in eczema patients linked to environmental allergens
Newly identified pathway explains why antihistamine drugs often don’t work to control severe itch
Credit: Illustration by Madison Mack
In addition to a skin rash, many eczema sufferers...
Genomics in the Clinic: A Candid Conversation with Sema4 CEO Eric Schadt
Eric Schadt, PhD, founder and CEO of Sema4, spoke with Chris Anderson (Editor-in-Chief, Clinical OMICs) about the founding of Sema4 and how it plans to help deliver actionable information for precision medicine . ....
Pfizer backing biotechnology innovation with $120m capital outlay – BioPharma-Reporter.com
Established in June 2020, the Pfizer Breakthrough Growth Initiative (PBGI) focuses on non-controlling equity investments primarily in public companies with small- to medium-sized market capitalizations and mature private companies that are developing clinical-stage assets aligned with...
Novel compound appears to protect myelin and nerve fibers
A compound developed at Oregon Health & Science University appears to protect nerve fibers and the fatty sheath, called myelin, that covers nerve cells in the brain and spinal cord. The discovery, published in...
Study reveals cardiac protein as a new target for different types of heart disease
Like a failing fuel pump that causes a loss of engine power in a car, a diseased heart can take a serious toll on the body's performance. For some patients, tasks like walking up...
Building a giant 2D map of the universe to prepare for the largest 3D...
Nearly 200 researchers pitched in to gather, process, and stitch together images for half of the sky to prepare for the start of the Dark Energy Spectroscopic Instrument’s observations
Credit: DESI Legacy Imaging Surveys
Before DESI,...
